- Investopedia•7 hours ago
Some large drug companies are working hard to develop a treatment that could generate a big payout.
- GlobeNewswire•12 hours ago
Breda, the Netherlands / Ghent, Belgium - argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment ...
- Forbes•3 days ago
Todd Hagopian recently identified five sub-sectors of Biotech poised for the best potential returns under President Trump. Today Todd gives us a deep dive into NASH (Nonalcoholic Steatohepatitis), the sub-sector that he is most excited about for 2017.
SHPG : Summary for Shire plc - Yahoo Finance
Shire plc (SHPG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||182.15 x 200|
|Ask||182.21 x 300|
|Day's Range||180.14 - 183.15|
|52 Week Range||161.09 - 209.22|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||146.69|
|Dividend & Yield||0.80 (0.44%)|
|1y Target Est||N/A|